Cefpodoxime
Reading File
Finding Sources
Searching PubMed
cefpodoxime clinical use spectrum
Reading File
Reading File
Reading File
Reading File
Reading File
Here is a detailed profile of Cefpodoxime drawn from Katzung's Pharmacology (16th ed.), The Harriet Lane Handbook (23rd ed.), and other clinical references:
Cefpodoxime (Cefpodoxime Proxetil)
Brand name: VANTIN (previously; now generics only)
Class: Third-generation oral cephalosporin - β-lactam antibiotic
Mechanism of Action
Cefpodoxime inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), disrupting peptidoglycan cross-linking. This results in bactericidal activity. It is a prodrug - cefpodoxime proxetil is an ester form that undergoes de-esterification in the GI tract to release the active cefpodoxime.
Antimicrobial Spectrum
As a third-generation cephalosporin, cefpodoxime has expanded gram-negative coverage compared to earlier generations (Katzung, 16th ed.):
Gram-positive:
- Streptococcus pneumoniae (oral 3rd-gen agents retain activity but less than ceftriaxone/cefotaxime)
- Streptococcus pyogenes (Group A strep)
- Staphylococcus aureus (MSSA) - moderate activity; poor against MRSA
Gram-negative:
- Haemophilus influenzae (including β-lactamase-producing strains)
- Moraxella catarrhalis
- Neisseria gonorrhoeae
- E. coli, Klebsiella pneumoniae, Proteus mirabilis
- Citrobacter, Serratia marcescens, Providencia
Limitations:
- No activity against Pseudomonas aeruginosa
- Not reliable against Enterobacter spp. (inducible AmpC β-lactamase)
- Susceptible to ESBL-producing organisms
- Poor against anaerobes
Compared to cefixime, cefpodoxime has better activity against pneumococci and S. aureus - cefixime is much less active against these organisms. - Katzung's Basic and Clinical Pharmacology, 16th ed.
Pharmacokinetics
| Parameter | Details |
|---|---|
| Route | Oral only |
| Prodrug | Yes - proxetil ester, hydrolyzed in GI tract |
| Food effect | Tablets: take WITH food (enhances absorption); suspension may be given without regard to food |
| Renal excretion | Yes - dose adjustment required in renal failure |
| Half-life | ~2-3 hours |
Drug Interactions:
- Antacids / H2 blockers (high dose): Reduce absorption of cefpodoxime - avoid or separate
- Probenecid: Increases serum cefpodoxime levels (blocks tubular secretion)
Clinical Indications & Dosing
Pediatric (2 months - 11 years) - Harriet Lane Handbook, 23rd ed.
| Indication | Dose | Duration |
|---|---|---|
| Otitis media | 10 mg/kg/24 hr PO ÷ Q12h | 5-10 days; max 400 mg/24 hr |
| Pharyngitis/tonsillitis | 10 mg/kg/24 hr PO ÷ Q12h | 5-10 days; max 200 mg/24 hr |
| Acute maxillary sinusitis | 10 mg/kg/24 hr PO ÷ Q12h | 10 days; max 400 mg/24 hr |
Adult (≥12 years) - Harriet Lane Handbook, 23rd ed.
| Indication | Dose | Duration |
|---|---|---|
| Exacerbation of chronic bronchitis | 400 mg/24 hr PO ÷ Q12h | 10 days |
| Community-acquired pneumonia | 400 mg/24 hr PO ÷ Q12h | 14 days |
| Sinusitis | 400 mg/24 hr PO ÷ Q12h | 10 days |
| Pharyngitis/tonsillitis | 200 mg/24 hr PO ÷ Q12h | 5-10 days |
| Skin/skin structure infection | 800 mg/24 hr PO ÷ Q12h | 7-14 days |
| Uncomplicated UTI | 200 mg/24 hr PO ÷ Q12h | 5-7 days |
Katzung gives the adult dose as 200-400 mg twice daily.
Adverse Effects
- Diarrhea, nausea, vomiting
- Vaginal candidiasis (superinfection)
- Transient elevation of ALT/SGPT
- False-positive urine reducing substance tests (Clinitest, Benedict's, Fehling's solution) - use enzymatic glucose oxidase tests (Clinistix, Tes-Tape) instead
- False-positive Coombs test
- Use with caution in penicillin-allergic patients (cross-reactivity ~1-2%)
Special Uses
- Gonorrhea (N. gonorrhoeae): Listed as a treatment option alongside ceftriaxone and cefixime - though ceftriaxone IM remains the preferred regimen (Red Book 2021; Quick Compendium of Clinical Pathology)
- Acute otitis media (treatment failure/penicillin-non-susceptible pneumococci): Oral cefdinir, cefpodoxime, or cefuroxime recommended as step-up therapy in addition to high-dose amoxicillin-clavulanate or IM ceftriaxone (Red Book 2021)
- Chronic rhinosinusitis with penicillin-resistant pneumococci: Combination with clindamycin is recommended (cefixime or cefpodoxime + clindamycin) - Cummings Otolaryngology
- UTI: Noted as an option for uncomplicated cystitis in young women, though clinical data for 3-day regimens are limited vs. nitrofurantoin/TMP-SMX (Comprehensive Clinical Nephrology, 7th ed.)
Recent Evidence
A 2024 systematic review on cefpodoxime pharmacokinetics (PMID 39120118) provides updated PK/PD data. A 2026 network meta-analysis (PMID 42440760) of 64 RCTs on Group A strep pharyngitis evaluates cefpodoxime among 24 antibiotics - relevant for tonsillitis dosing decisions.
Summary Mnemonic
CUPS - Cefpodoxime covers:
- Community respiratory infections (otitis, sinusitis, pharyngitis, pneumonia)
- UTI (uncomplicated)
- Prodrug (proxetil ester)
- Skin infections
This is a shared conversation. Sign in to Orris to start your own chat.